Index
1207
torsional and angular defor-
mities of, 1098–1100,
1098
f
–1100
f
venous circulation of, 436, 437
f
Extrinsic apoptosis, 43, 43
f
Extrinsic reflexes, 421
Exudates, 60, 568
Exudative retinal detachment, 965
Eye, 955, 956
f
muscles of, 971, 971
f
, 972
t
Eye disorders, 955–973
conjunctivitis, 957–958, 958
f
corneal, 959–960
lens, 960–961, 960
f
movement, 971–974,
971
f
–972
f
, 972
t
neural, 969–971, 970
f
retinal, 961–967, 962
f
–964
f
,
966
f
Factor VIII replacement therapy,
272–273
Fallopian tubes, 1019
f
, 1020
Falx cerebri, 844, 844
f
Farsightedness.
See
Hyperopia
FAS.
See
Fetal alcohol syndrome
Fascicles, 24, 24
f
, 824
Fasting plasma glucose (FPG), 805
Fast response, cardiac action
potential, 388, 388
f
Fat embolism syndrome (FES),
1090
Fatigue
in cancer, 145
with heart failure, 494–495
Fatigue stress fracture, 1084
Fat necrosis, 1043
Fats
digestion and absorption of,
691–692, 692
f
, 717, 718
t
liver in, 727, 727
t
, 728
f
energy requirements for, 226
metabolism and storage of, 794
for wound healing, 81
Fatty liver disease, 738, 738
f
nonalcoholic, 739
Fatty streaks, 410, 410
f
Febrile seizures, 945
Feedback regulation, of hormones,
762, 763
f
Feedback systems, for homeosta-
sis, 207–208, 207
f
Female athlete triad, 1113
Female reproductive system.
See
specific components
Femoral epiphysis, slipped capi-
tal, 1105–1106
Femoral torsion, 1099–1100,
1099
f
–1100
f
Fenestrations, 396, 602, 602
f
Ferritin, 279, 279
f
FES.
See
Fat embolism syndrome
Fetal alcohol syndrome (FAS),
122–123, 122
f
Fetal biopsy, 126
Fetal hemoglobin (HbF), 278
α
-Fetoprotein (AFP), for prenatal
screening and diagnosis, 124
Fetor hepaticus, 742, 743
f
FEV.
See
Forced expiratory
volume
Fever
body temperature regulation
and, 63–65, 63
f
, 64
f
, 64
t
in children, 68
in elderly, 68
febrile response, 65–66, 66
f
management of, 67
manifestations of, 67
Fever of unknown origin (FUO), 67
Fiber, requirements of, 227
Fibrillation, 389
Fibrinolytic drugs, for myocardial
infarction, 452–453
Fibrinous exudates, 60
Fibroblasts, 77, 77
f
in healing, 79, 82, 82
f
Fibrocartilage, 1064
Fibrocartilaginous callus forma-
tion, in fracture healing, 1086,
1086
f
, 1088
Fibroma, 130, 131
t
Fibrosarcoma, 130, 131
t
Fibrosis, 78
Fibrous atheromatous plaque,
410, 410
f
, 412, 413
f
Fibrous joints, 1074
Fibrous proteins, 28, 77
Fibrous skeleton, of heart,
384–386, 384
f
Fight-or-flight response, 210
Filtrate, 602–603, 602
f
Filtration slits, 602
f
, 603
Fimbriae, 300, 308
Fingernails, 1147–1148, 1147
f
First-degree burn, 1168
Flaccid bladder, 659
f
, 663
Flagella, 7, 300
Floppy mitral valve syndrome,
462–463, 462
f
Fluids, 159–167, 160
f
, 161
t
capillary/interstitial exchange
of, 164
f
–165
f
compartmental distribution of,
162–163, 162
f
osmosis of, 161–162, 161
f
retention of, with heart failure,
494
third-space accumulation of,
166–167
tonicity of, 162, 162
f
water and sodium balance, 167
disorders of, 171–176, 172
f
Flush, 67
Focal segmental glomerulosclero-
sis, 625–626
Focal seizures, 945–946
Folic acid, deficiency in, 123
Folic acid-deficiency anemia, 289
Follicles
hair, 1147, 1147
f
in lymph system, 245–246,
246
f
in ovaries, 1022
f
, 1023–1024
in thyroid, 776, 776
f
Follicular lymphomas, 254, 254
c
Fomites, 307
Food
allergies to, 347–348
intake of, regulation of,
227–228, 227
f
Foot ulcers, diabetic, 816–817, 817
f
Foramen ovale, 477, 477
f
Forced expiratory volume (FEV),
526, 526
t
Forced vital capacity (FVC), 526,
526
t
in asthma, 575
Forebrain, 833
t
–834
t
, 840
f
,
841–843, 843
f
–844
f
Foreign body, wound healing
and, 84
Foreign body giant cell, 62, 62
f
FPG.
See
Fasting plasma glucose
Fracture blisters, 1089
Fractures
bone healing, 1085–1088,
1086
f
–1087
f
classification of, 1084–1085,
1084
f
complications of, 1088–1090,
1089
f
, 1089
t
diagnosis and treatment of,
1085
of hip, 1083–1084, 1083
f
manifestations of, 1085, 1085
f
osteoporosis, 1113–1114,
1114
f
Fragile X syndrome, 112–113
Frank-Starling mechanism, 392,
393
f
, 488–489, 489
f
FRC.
See
Functional residual
capacity
Free nerve endings, 858
Free radicals
in acute inflammation, 59–60
aging and, 46
cellular injury caused by,
39–41, 40
f
Frontal lobe, 842, 843
f
Frontotemporal dementia (FTD),
951
Fructose, digestion and absorp-
tion of, 690, 691
f
, 691
t
FTD.
See
Frontotemporal dementia
Full-thickness skin graft, for
thermal injury, 1171
Fulminant hepatitis, 736
Functional residual capacity
(FRC), 526, 526
f
Fundus, 677, 677
f
Fungal infections
of respiratory tract, 551–552
of skin, 1153–1156,
1154
f
–1156
f
Fungi, 304–305, 304
f
FUO.
See
Fever of unknown
origin
Fusiform aneurysm, 417, 417
f
FVC.
See
Forced vital capacity
GAGs.
See
Glycosaminoglycans
Galactose, digestion and absorp-
tion of, 690, 691
f
, 691
t
Gallbladder
cancer of, 748
disorders of, 745–748, 746
f
Gamma motor neurons, 885, 885
f
Gangliosidoses, 111
Gangrene, 44–45, 44
f
Gap junctions, 27, 28
f
, 826
Gap phases, of cell cycle, 72–75,
74
f
–75
f
GAS.
See
General adaptation
syndrome
Gas(es)
basic properties of, 520–521
diffusion of, 529–530
exchange and transport of,
528–534
in neonates and children, 556
Gas gangrene, 44–45
Gastric acid, secretion of,
686–687, 687
f
Gastric inhibitory peptide.
See
Glucose-dependent insulino-
tropic peptide
Gastric mucosal barrier, 701
Gastric secretion, 686–687, 686
t
,
687
f
Gastrin, 688
t
, 689
Gastritis, 701–703, 702
f
Gastroesophageal reflux disease
(GERD), 698–699, 698
f
in children, 699–700
Gastroesophageal sphincter, 677
reflux, 698
f
Gastrointestinal system
CKD and, 645
f
, 646, 651
digestion and absorption in,
687–688, 688
f
, 690–692
carbohydrates, 690, 691
f
,
691
t
fats, 691–692, 692
f
protein, 691
disorders of, 696–721
with spinal cord injury,
911–912
hormones of, 688–689, 688
t
intestinal flora, 692–693
lower, organization of, 676
f
, 677
motility in, 680
colon, 685
control of, 680–681
disorders of, 713–716,
714
c
, 716
f
–717
f
gastric, 684
small intestine, 682–685,
682
f
–683
f
, 685
f
swallowing and esophageal,
681, 684, 682
f
organization of, 675–679,
676
f
–677
f
secretions of, 686–688, 686
t
,
687
f
shock and, 508
small intestine, organization
of, 676
f
, 677
thyroid hormone and, 778
upper, organization of,
676–677, 676
f
–677
f
wall structure of, 677–678,
678
f
–679
f
Gastrointestinal tract infections,
with HIV, 367–368
Gate control theory, of pain, 860
G-CSF.
See
Granulocyte colony-
stimulating factors
GDM.
See
Gestational diabetes
Gender, adaptation and, 214
Gene dosage studies, for genetic
mapping, 100
General adaptation syndrome
(GAS), 208
Generalized bronchiectasis, 583
Generalized seizures, 945
c
,
946–947
Generalized vulvodynia, 1026
General somatic afferent (GSA)
neurons, 833, 833
f
, 854
General somatic efferent (GSE)
neurons, 833
f
, 835
General visceral afferent (GVA)
neurons, 833, 833
f
, 854
General visceral efferent (GVE)
neurons, 833
f
, 835
